1-3 of 3
Miguel Angel Pozas
Close
Sort by
Journal Articles

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Clinical Trials & Observations
Tomás José González-López, Nuria Bermejo-Vega, Rocío Cardesa-Cabrera, Violeta Martínez-Robles, Gerardo Aguilar-Monserrate, Gloria Pérez-Segura, Abel Domingo, Josefa Luis-Navarro, Sunil Lakhwani, Natalia Acedo, María Luisa Lozano, Silvia Bernat, Ana Torres-Tienza, Ana Ruano, Isidro Jarque, Pilar Galán, Carmen Benet, Shally Marcellini, Reyes Jimenez-Bárcenas, Daniel Martínez-Carballeira, Dunia De Miguel-Llorente, Alvaro Perona-Blázquez, Isabel Gonzalez-Gascón, Elsa Lopez-Ansoar, José María Alonso-Alonso, María Luisa Bengochea-Casado, Francisco Javier Díaz-Gálvez, Ana Moretó, Gemma Moreno-Jiménez, Roberto Hernández-Martin, Erik de Cabo, Julio Dávila-Valls, Amalia Cuesta, Carmen Pastoriza, Gerardo Julio Hermida-Fernández, Covadonga García, Miguel Angel Pozas-Mañas, Carlos Aguilar, Dolores Fernandez-Jimenez, Begoña Navas-Elorza, Carolina López-Santamaría Castro, Alvaro Lorenzo, Xavier Ortín, Marta García, Sonia Piernas, Johana Díaz-Santa, Inmaculada Soto, Drew Provan, Gloria García-Donas Gabaldón
Journal: Blood
Blood (2024) 144 (6): 646–656.
https://doi.org/10.1182/blood.2024024250
Published: 2024
Journal Articles

Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry

Tomas Jose Gonzalez-Lopez, Gloria Perez Segura, Abel Domingo, Elsa Lopez Ansoar, Francisco Javier Diaz Galvez, Reyes Jimenez Barcenas, Daniel Martinez Carballeira, Dunia De Miguel Llorente, Alvaro Perona Blazquez, Gerardo Aguilar-Monserrate, Julio Dávila-Valls, Isabel Gonzalez Gascon, Amalia Cuesta, María Luisa Bengochea Casado, Gerardo Julio Hermida Fernandez, Jose Maria Alonso Alonso, Miguel Angel Pozas Mañas, Ana Torres-Tienza, Carlos Aguilar, Dolores Fernandez-Jimenez, Inmaculada Soto, Silvia Bernat
Journal: Blood
Blood (2023) 142 (Supplement 1): 2591.
https://doi.org/10.1182/blood-2023-190511
Published: 2023
Journal Articles

ERG, EVI1 and PRAME Are Relevant Markers of Treatment Response and Survival, and They Could Be Useful for Improving the Risk-Stratification in Citogenetically Normal Acute Myeloid Leukemia (CN-AML)

Carlos Santamaría, Carmen Chillón, Ramon García-Sanz, Cristina Pérez, Fernando Ramos, Alfonso García de Coca, Jose- Maria Alonso, Pilar Giraldo, Teresa Bernal, José-Antonio Queizán, José Nicolas Rodríguez, Pascual Fernández-Abellán, Abelardo Barez, María-José Peñarrubia, Mari Luz Amigo, Alejandro Martín García-Sancho, Miguel Angel Pozas, Ana Balanzategui, Joaquin Díaz-Mediavilla, Jesús F. San Miguel, Marcos González
Journal: Blood
Blood (2008) 112 (11): 4844.
https://doi.org/10.1182/blood.V112.11.4844.4844
Published: 2008